Warwick Investment Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.23M Buy
1,024
+200
+24% +$204K 0.14% 61
2026
Q1
$758K Sell
824
-13
-2% -$13.2K 0.11% 65
2025
Q4
$900K Buy
837
+105
+14% +$100K 0.14% 62
2025
Q3
$559K Buy
732
+34
+5% +$25.3K 0.1% 72
2025
Q2
$544K Buy
698
+25
+4% +$19.4K 0.11% 64
2025
Q1
$556K Buy
673
+160
+31% +$133K 0.12% 62
2024
Q4
$396K Sell
513
-34
-6% -$28.2K 0.08% 62
2024
Q3
$485K Buy
547
+8
+1% +$7.19K 0.11% 51
2024
Q2
$488K Buy
539
+75
+16% +$60K 0.11% 59
2024
Q1
$361K Buy
+464
New +$330K 0.09% 67

Other funds holding LLY

Warwick Investment Management's LLY Position: Q2 2026 in Review

Warwick Investment Management increased its Eli Lilly (LLY) stake by 24% in Q2 2026, buying an estimated $204K and bringing the position to 1,024 shares worth $1.23M. The position accounts for 0.14% of the portfolio, ranked #61.

Warwick Investment Management first reported a position in LLY in Q1 2024 and has held it in 10 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Warwick Investment Management held 1,024 shares of Eli Lilly worth $1.23M as of Q2 2026.
  • Warwick Investment Management bought 200 Eli Lilly shares in Q2 2026, an estimated $204K.
  • Eli Lilly made up 0.14% of Warwick Investment Management's portfolio in Q2 2026, its #61 holding.
  • Warwick Investment Management first reported a position in Eli Lilly in Q1 2024 and has held it in 10 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Warwick Investment Management's 13F filing for Q2 2026, filed 31 Jul 2026.